The advance of technology has influenced marketing in a number of ways that have ethical implications. Growth in use of the Internetand e-commerce has placed electronic “cookies,” spyware, spam, RFIDs, and data mining at the forefront of the ethical debate. Some marketers have minimized the significance of these trends. This overview paper examines these issues and introduces the two articles that follow. It is hoped that these entries will further the important “marketing and technology” ethical debate.

This paper begins by examining several potentially unethical recent marketing practices. Since most marketing managers face ethical dilemmas during their careers, it is essential to study the moral consequences of these decisions. A typology of ways that managers might confront ethical issues is proposed. The significant organizational, personal and societal costs emanting from unethical behavior are also discussed. Both relatively simple frameworks and more comprehensive models for evaluating ethical decisions in marketing are summarized. Finally, the fact that organizational commitment to (...) fostering ethical marketing decisions can be accomplished by top management leadership, codes of ethics, ethics seminars/programs and ethical audits is examined. (shrink)

Time was when you could bite a tomato and not ingest fish genes. Time was when you could eat french fries and just worry about the fat and salt, not the bacterial genes that produce insecticides in the potato. Those times are over, thanks to corporate control over both genetic engineering and the lack of food-labeling. Unless you are a “hard core” consumer of organic foods, you eat genetically engineered foods everyday. While 80-90% of US consumers believe genetically engineered foods (...) should be labeled, only 3% know they already on the market.[1] Today 60-70% of the food in a grocery store contains components from genetically modified crops. Moreover, this technology was unleashed on over 45 million acres of US farmland last year alone, after having been commercially introduced only four years ago.[2] Here we will provide a brief background on the types of genetically engineered crops that are being surreptitiously forced upon consumers, then argue against their current widespread use. (shrink)

Abstract:This study examined the relationship between the individual difference variables of personal moral philosophy, locus of control, Machiavellianism, and just world beliefs and ethical judgments and behavioral intentions. A sample of 602 marketing practitioners participated in the study. Structural equation modeling was used to test hypothesized relationships. The results either fully or partially supported hypothesized direct effects for idealism, relativism, and Machiavellianism. Findings also suggested that Machiavellianism mediated the relationship between individual difference variables and ethical judgments/behavioral intentions.

In an effort to assess the latest thinking in the Roman Catholic Church on economic matters, we examine the newest encyclical by Pope Benedict XVI, Caritas in Veritate (Charity in Truth) for guidance concerning marketing and business strategy. Core ethical values, consistent with historical Catholic Social Teachings (CST), are retained. However, some important nuances are added to previous treatments, and, reflecting the mind of the current Pontiff, certain points of emphasis are shifted to account for recent global developments. Key areas (...) of consistency and differences (as we perceive them) are spelled out along with some brief commentary on the evolution of the CST position on matters of importance to business decision makers. We close our analysis with a brief discussion of how the lessons of the encyclical can be applied to selected marketing problems embedded with ethical issues, including some criteria for evaluating marketing programs. Finally, we note some editorial commentary published in the wake of the letter’s release along with our own summation. (shrink)

This paper provides a marketing ethics analysis that addresses the practice of selling genetic tests directly to the consumer. It details the complexity of this emergent sector by articulating the panoply of evolving ethical/social questions raised by this development. It advances the conversation about DTC genetic testing by reviewing the business and healthcare literature concerning this topic and by laying out the inherent ethical complications for consumers, marketers, and regulators. It also points to several possible public and company policy adjustments. (...) Because this area is relatively new and incredibly dynamic, its current discussion is necessarily an exercise in the “logic of discovery” rather than the “protocol of validation”. The paper serves as a primer for the types of GT being promoted. It also calls for a public discourse in the academic and general community to uncover and define the ethical guidelines and systemic adjustments necessary to create fairness in the various DTC transactions occurring between genetic test sellers and the buyers/clients of their services. (shrink)

The present study extends the study of individuals' ethical ideology withinthe context of marketing ethics issues. A national sample of marketing professionals participated. Respondents' ethical ideologies were classified as absolutists, situationists, exceptionists, or subjectivists using the Ethical Position Questionnaire (Forsyth, 1980). Respondents then answered questions about three ethically ambiguous situations common to marketing and sales. The results indicated that marketers' ethical judgments about the situations differed based on their ethical ideology, with absolutists rating the actions as most unethical. The findings (...) are consistent with those of two earlier studies that utilized samples of business students (Barnett et al., 1994, 1995). The results suggest that personal moral philosophy is an important influence on ethical decision making that should be considered in empirical studies of business ethics. The results also support the utility of the Ethical Position Questionnaire (Forsyth, 1980) as a means for researchers and practitioners to assess individuals' ethical ideology. (shrink)

This paper brings Lyotard into connection with the discussions of Socrates in REPUBLIC concerning general libidinal economy and its relation to the logos in human beings. Since desire is always the desire to be amoral -- not to recognize the person as subject, but rather recognizing it as a market for the capital gain of desire, it is to be suspected that desire within the subject is the cause of so-called differends between subjects. This is what Republic is about.

Tyler Cowen's ?Why Keynesianism Triumphed? proposed that only Keynesian economists have presented a successful explanation for the Great Depression of 1929?1933 and the continuing slow and intermittent recovery of the rest of the 1930s. This paper examines recent scholarship on the 1930s and finds that there is increasing doubt about the validity of Keynesian explanations, lending credence to both older and recent scholarship that vindicates free?market views of why the Depression happened and why the recovery was so slow and (...) uneven. (shrink)

Writing in the Business and Politics, Santos and Laczniak 2012) formulated a normative, ethical approach to be followed when marketers e ngage impoverished market segments. It is labeled the integrative justice model. As noted below, that approach called for authentic engagement, co-creation, and customer interest representation, among other elements, when transacting with vulnerable market segments. Basically, the IJM derived certain operational virtues, implied by moral philosophy, to be used when marketing to the poor. But this well-intentioned approach raises (...) a significant “So what?” question. Are such sentiments anything but lofty aspirations for idealists or are there steps to be taken by society and business managers of goodwill to make the adaptation of the IJM by corporations more likely and pragmatic? This paper begins to layout a roadmap that shows “how and why” the IJM might more likely be vitalized. The crux, as described below, is found in the transformational justice dimensions that are embedded in institutions ; such external institutions provide a “power” impetus to assure the ethical rights claims that impoverished consumers have owed to them. In this way, the ideal exchange characteristics for bottom of the pyramid markets argued for in the IJM can become actively transformational. The main contribution of this paper is that it begins to chart out the institutional system elements that need to exercise power in order to deliver a “fairer” marketplace for BoP consumers. (shrink)

The “justice of markets” is intricately connected to the treatment of the poor and the disadvantaged in market economies. The increased interest of multinational corporations in low-income market segments affords, on one hand, the opportunity for a more inclusive capitalism, and on the other, the threat of greater exploitation of poor and disadvantaged consumers. This article traces the contributions of Catholic Social Teaching and its basic principles toward providing insight into what constitutes “justice” in such “marketing to the (...) impoverished” situations. (shrink)

This clever and insightful book reveals the depth and breadth of high moral character and competence in the corporate world. The good news is that the corporate world, by and large, is in good shape. The bad news is that the bad apples number enough to make the rest of us vulnerable to their whims. A Knight?s Code of Business is the first book to arrive in the aftermath of high profiles disasters such as Enron and WorldCom. It presents both (...) the misadventures that befall corporations, as well as guidance to help upcoming managers achieve high moral character and competence in the corporate world. It?s a fun and insightful read. The lessons discussed come from the author?s 20+ years of experience, stories contributed by nearly two dozen other business professionals all across America, and the new survey of marketing executives. (shrink)

The slandering of a firm’s products by competing firms poses significant threats to the victim firm, with the resulting damage often being as harmful as that from product-harm crises. In contrast to a true product-harm crisis, however, this disparagement is based on a false claim or fake news; thus, we call it a pseudo-product-harm crisis. Using a pseudo-product-harm crisis event that involved two competing firms, this research examines how consumer sentiments about the two firms evolved in response to the crisis. (...) Our analyses show that while both firms suffered, the damage to the offending firm was more detrimental, in terms of advertising effectiveness and negative news publicity, than that to the victim firm. Our study indicates that, even apart from ethical concerns, the false claim about the victim firm was not an effective business strategy to increase the offending firm’s performance. (shrink)

Gene-technology was developed in the eighties and stimulated an overmuch heated social debate. Let's think such problems as cloning, transgenic organisms, Human Genom Project, DNA diagnostics and therapy, the geneticalisation of society etc. While the gene manipulation develops rapidly the necessary social control is missing. Regarding the social co-ordination of gene technology, the decision-makers still excessively trust in the institution of market and in the experts' competence.

Abstract:This paper considers the relevance of the concept of “eugenics,”—a term associated with some of the most egregious crimes of the twentieth century—to the possibility of editing human genomes. The author identifies some uses of gene editing as eugenics but proposes that this identification does not suffice to condemn them. He proposes that we should distinguish between “morally wrong” practices, which should be condemned, and “morally problematic” practices that call for solutions, and he suggests that eugenic uses of (...) class='Hi'>gene editing fall into this latter category. Although when we choose the characteristics of future people we are engaging in morally dangerous acts, some interventions in human heredity should nevertheless be acknowledged as morally good. These morally good eugenic interventions include some uses of preimplantation genetic diagnosis. The author argues that we should think about eugenic interventions in the same way that we think about morally problematic interventions in public health. When we recognize some uses of gene editing as eugenics, we make the dangers of selecting or modifying human genetic material explicit. (shrink)

This chapter discusses some of the practical consequences of the recent and evolving situation in both science and industry, and forecasts how altering the law might affect each. It considers at least three possibilities: (1) justice demands eradicating patenting genes no matter what the consequences, (2) justice and economic efficiency demand altering the current system to meet both concerns, or (3) the economic effects of altering or eradicating the present system outweigh both the concerns of justice or economic efficiency, and (...) so the status quo should be maintained. The chapter explores each of these possibilities with an eye toward actually proposing rational public policy scenarios that could be adopted. Open Source essentially amounts to the ideal methods of the sciences applied to products in the marketplace. DNA in its natural state is the object of discovery and therefore the domain of science. (shrink)

Although the U.S. Patent and Trademark Office (“PTO”) has granted patents on genes for over 20 years, the prudence of gene patenting continues to stir controversy. Some have questioned the ethics of monopolizing a resource that is so fundamental and basic to all living organisms. It has also been argued that patents unfairly restrict the use of genes, impeding both basic and commercial research. For the biotechnology industry, however, gene patents are the currency it uses to protect its (...) investment in research and development, and eventually, the products it brings to market. This paper examines the eligibility of genes for patenting, and considers whether the policy reasons that have led courts to decide that certain categories of subject matter are unpatentable, apply to the realm of genes. Even if this were the case, this does not mean that biotech companies have no way of protecting their inventions. Methods and processes of using the genes do not invoke the same policy considerations, and may provide a more appropriate way of rewarding industry for the narrow discovery of a gene’s specific use. (shrink)

In recent years there has been much philosophical discussion over the question of whether the prohibitions on markets in such items as human body parts and gene sequences, and services such as human reproductive labor and sex, should be lifted. Yet despite the attention paid to this issue there are been surprisingly little discussion of the question of whether markets in certain items that are currently freely traded should be restricted or eliminated. In particular, there has been little discussion (...) of the question of whether markets in items that could be readily used to deceive people should be restricted. I argue in this paper that one of the central moral values of the contemporary West – respect for personal autonomy – requires that such markets be restricted. (shrink)

Clinical gene transfer research has both a unique history and a complex and layered system of research oversight, featuring a unique review body, the Recombinant DNA Advisory Committee. This paper briefly describes the process of decision-making about clinical GTR, considers whether the questions, problems, and issues raised in clinical GTR are unique, and concludes by examining whether the RAC's oversight is a useful model that should be reproduced for other similar areas of clinical research.Clinical GTR is governed by the (...) same oversight system as most clinical trials, with a significant addition: the RAC. Like other research with human subjects, GTR, if it is affiliated with a federally funded institution, must be approved by an institutional review board whose activities are governed by the common rule, that is, the federal regulations for protection of human subjects in research. Like other research intended to produce a drug, device, or biologic to be marketed in the United States, GTR is also overseen by the Food and Drug Administration. (shrink)

The patenting of human genes has been the subject of debate for decades. While China has gradually come to play an important role in the global genomics-based testing and treatment market, little is known about Chinese scholars’ perspectives on patent protection for human genes. A content analysis of academic literature was conducted to identify Chinese scholars’ concerns regarding gene patents, including benefits and risks of patenting human genes, attitudes that researchers hold towards gene patenting, and any legal (...) and policy recommendations offered for the gene patent regime in China. 57.2% of articles were written by law professors, but scholars from health sciences, liberal arts, and ethics also participated in discussions on gene patent issues. While discussions of benefits and risks were relatively balanced in the articles, 63.5% of the articles favored gene patenting in general and, of the articles that explored gene patents in the Chinese context, 90.2% supported patent protections for human genes in China. The patentability of human genes was discussed in 33 articles, and 75.8% of these articles reached the conclusion that human genes are patentable. Chinese scholars view the patent regime as an important legal tool to protect the interests of inventors and inventions as well as the genetic resources of China. As such, many scholars support a gene patent system in China. These attitudes towards gene patents remain unchanged following the court ruling in the Myriad case in 2013, but arguments have been raised about the scope of gene patents, in particular that the increasing numbers of gene patents may negatively impact public health in China. (shrink)

Personalized genomics companies (PG; also called ‘direct-to-consumer genetics’) are businesses marketing genetic testing to consumers over the Internet. While much has been written about these new businesses, little attention has been given to their roles in science communication. This paper provides an analysis of the gene concept presented to customers and the relation between the information given and the science behind PG. Two quite different gene concepts are present in company rhetoric, but only one features in the science. (...) To explain this, we must appreciate the delicate tension between PG, academic science, public expectation, and market forces. (shrink)

In most traditions, the law is founded upon some extralegal view of morality. There are only a handful of cases prior to the 1970s that involved patenting nonhuman organisms. John Moore made several claims, but the one of most interest to us here was a claim for conversion, which means the unlawful use of another person's property for the enrichment of the person using the thing unlawfully. The cell line produced from Moore's spleen cells was eventually patented by the defendants. (...) The potential market for products relating to that patent was estimated to be roughly $3 billion US dollars. The move from patenting hybridized plants, to genetically altered microorganisms, to human tissues and genes reflected the epitome of the fabled slippery slope. There is clearly a gap between our intuitions about the relations between our individual genomes, our identities, perceptions of privacy and personal autonomy, and the law. (shrink)

National traditional handicrafts are an important part of China’s excellent traditional culture. Inheriting and carrying forward traditional handicrafts is a proposition of the times given to us by history. Grounded theory research methods were used to code texts, interviews, and observations related to Miao embroidery culture, and explore the dilemmas and opportunities for the inheritance of Miao embroidery culture in the current market environment and cultural environment. This article forms a basic theoretical framework for realizing the living inheritance path (...) of Miao embroidery through the identification and decoding of Miao embroidery cultural genes. The study found that the means of translating Miao embroidery cultural genes include schema reconstruction, product development, branding, and cultural interpretation; the ways of transmitting Miao embroidery cultural genes include collaborative innovation, cross-border development, and multi-dimensional applications. Finally, a living inheritance practice model of Miao embroidery based on gene decoding, gene translation, and gene transmission was constructed. The theoretical model was used to guide the inheritance practice and promote Miao embroidery to produce positive development effects in the three aspects of society, economy, and culture. The core concept of "living inheritance" discussed in this article is reflected in the contemporary value recognition and value transformation of "cultural genes". In the context of cultural self-confidence, this study combines Chinese scenarios to provide policy suggestions for carrying out design innovation, implementing brand strategies, broadening application fields, and promoting the living inheritance of Miao embroidery cultural genes. (shrink)

BackgroundSince 2006, the genetic testing company 23andMe has collected biological samples, self-reported information, and consent documents for biobanking and research from more than 1,000,000 individuals, through a direct-to-consumer online genetic-testing service providing a genetic ancestry report and a genetic health report. However, on November 22, 2013, the Food and Drug Administration halted the sale of genetic health testing, on the grounds that 23andMe was not acting in accordance with federal law, by selling tests of undemonstrated reliability as predictive tests for (...) medical risk factors. Consumers could still obtain the genetic ancestry report, but they no longer had access to the genetic health report in the United States. However, this did not prevent the company from continuing its health research, with previously obtained and future samples, provided that consent had been obtained from the consumers concerned, or with health reports for individuals from other countries. Furthermore, 23andMe was granted FDA authorization on February 19, 2015, first to provide reports about Bloom syndrome carrier status, and, more recently, to provide consumers with “carrier status” information for 35 genes known to cause disease.DiscussionIn this Debate, we highlight the likelihood that the primary objective of the company was probably two-fold: promoting itself within the market for predictive testing for human genetic diseases and ancestry at a low cost to consumers, and establishing a high-value database/biobank for research and personal information).SummaryBy dint of this marketing approach, a two-sided market has been established between the consumer and the research laboratories, involving the establishment of a database/DNA biobank for scientific and financial gain. We describe here the profound ethical issues raised by this setup. (shrink)

Gene editing in agriculture and food (GEAF) is a nascent development with few products and is unfamiliar among the wider US public. GEAF has garnered significant praise for its potential to solve for a variety of agronomic problems but has also evoked controversy regarding safety and ethical standards of development and application. Given the wake of other agribiotechnology debates including GMOs (genetically modified organisms), this study made use of 36 in-depth key interviews to build the first U.S. based typology (...) of proponent and critic priorities for shaping public trust in GEAF actors and objects. Key organizational actors provide early and foundational messaging, which is likely to contribute heavily to public salience, comprehension, and decision-making as potential consumers reflect upon their experiences, envision future outcomes, and consider the reputation of those trying to influence them. As is documented in our results, the trust-building priorities of these groups often stand in opposition to one another and are influenced by distinct motivations for how the public will come to trust or distrust GEAF actors and objects as more products are developed and enter the market. (shrink)

Computational drug repositioning has been proven as a promising and efficient strategy for discovering new uses from existing drugs. To achieve this goal, a number of computational methods have been proposed, which are based on different data sources of drugs and diseases. These methods approach the problem using either machine learning- or network-based models with an assumption that similar drugs can be used for similar diseases to identify new indications of drugs. Therefore, similarities between drugs and between diseases are usually (...) used as inputs. In addition, known drug-disease associations are also needed for the methods as prior information. It should be noted that those associations are still not well established due to the fact that many of marketed drugs have been withdrawn and this could affect the outcome of the methods. In this study, we propose a novel method named RLSDR to find new uses of drugs. More specifically, it relies on a semi-supervised learning model, Regularized Least Square, thus it does not require definition of non-drug-disease associations as previously proposed machine learning-based methods. In addition, the similarity between drugs measured by chemical structures of drug compounds and the similarity between diseases which share phenotypes can be represented in a form of either similarity network or similarity matrix as inputs of the method. Moreover, instead of using a gold-standard set of known drug-disease associations, we construct an artificial set of the associations based on known disease-gene and drug-target associations. Experiment results demonstrate that RLSDR achieves better prediction performance on the artificial set of drug-disease associations than that on the gold-standard ones in terms of area under the Receiver Operating Characteristic curve. In addition, it outperforms two representative network-based methods irrespective of the prior information of drug-disease associations. Novel indications for a number of drugs are also identified and validated by evidences from a different data resource. (shrink)

Myriad Genetics holds a patent on testing for the hereditary breast and ovarian cancer genes, BRCA1 and BRCA2, and therefore has a forced monopoly on this critical genetic test. Myriad launched a Direct-to-Consumer (DTC) marketing campaign in the Northeast United States in September 2007 and plans to expand that campaign to Florida and Texas in 2008. The ethics of Myriad's patent, forced monopoly and DTC campaign will be reviewed, as well as the impact of this situation on patient access and (...) care, physician liability, and the future of DTC campaigns for genetic testing. (shrink)

This paper looks at the commodification of interferon, marketed by Hoffmann La Roche as Roferon A in 1986, as a case study that helps us understand the role of pharmaceutical industry in cancer research, the impact of molecular biology on cancer therapy, and the relationships between biotech start-ups and established pharmaceutical firms. Drawing extensively on materials from the Roche company archives, the paper traces interferon’s trajectory from observed phenomenon to product. Roche embraced molecular biology in the late 1960s to prepare (...) for the moment when the patents on some of its bestselling drugs were going to expire. The company funded two basic science institutes to gain direct access to talents and scientific leads. These investments, I argue, were crucial for Roche’s success with recombinant interferon, along with more mundane, technical and regulatory know-how held at Roche’s Nutley base. The paper analyses in some detail the development process following the initial success of cloning the interferon gene in collaboration with Genentech. It looks at the factors necessary to scale up the production sufficiently for clinical trials. Using Alfred Chandler’s concept of ‘organizational capabilities’, I argue that the process is better described as ‘mobilisation’ than as ‘translation’. (shrink)

Might the 2018 birth of two designer babies in China write the opening paragraph for the next chapter in the history of eugenics? The worldwide scientific community has tacitly put a moratorium on human clinical application of CRISPR gene editing, waiting until unknown risks can become known. But this ethical agreement has been breached, and calls are now being heard for more rigorous regulations. Perhaps religious and spiritual leaders can join the bioethical chant: the yellow light of caution is (...) flashing. (shrink)

The future of art is dirt and decomposing shit. A deconstructed intestinal sea of microorganisms, spread out into the soil they were released back into following the extinction of their complex vessel. The genetic information they exchanged with each other as well as with their container, now existing in a vague memory, perhaps a feeling of sadness and longing, as they digest the once cherished artifacts of their human predecessors.

Creating Future People offers readers a fast-paced primer on how advances in genetics will enable parents to influence the traits of their children, including their children's intelligence, moral capacities, physical appearance, and immune system. It explains the science of gene editing and embryo selection, and motivates the moral questions it raises by thinking about the strategic aspects of parental choice. Professor Anomaly takes seriously the diversity of preferences parents have, and the limits policymakers face in regulating what will soon (...) be a global market for reproductive technology. Anomaly argues that once embryo selection for complex traits happens it will change the moral landscape by altering the incentives each person faces. All of us will take an interest in the traits everyone else selects, and this will present coordination problems that previous writers on genetic enhancement have failed to consider. Anomaly ends by considering how genetic engineering will transform humanity. Key Updates to the Second Edition · Significant revisions to the Preface and three separate chapters to include more details about what will be scientifically possible in the coming years and the moral issues these developments will raise · New and substantial coverage of embryo selection (guided by polygenic scores) for minimizing the risk of genetic diseases · Engagement with all important, new publications on the science of genetic enhancement. (shrink)

This paper focuses on the question of whether DNA patents help or hinder scientific discovery and innovation. While DNA patents create a wide variety of possible benefits and harms for science and technology, the evidence we have at this point in time supports the conclusion that they will probably promote rather than hamper scientific discovery and innovation. However, since DNA patenting is a relatively recent phenomena and the biotechnology industry is in its infancy, we should continue to gather evidence about (...) the effects of DNA patenting on scientific innovation and discovery as well the economic, social, and legal conditions relating to intellectual property in biotechnology. We should give the free market, the courts, researchers, and patent offices a chance to settle issues related to innovation and discovery, before we seek legislative remedies, since new laws proposed at this point would lack adequate foresight and could do more harm than good. However, we should be open to new laws or regulations on DNA patents if they are required to in order to deal with some of the biases and limitations of the free market. (shrink)

Gene-Culture Coevolution (GCC) theory is an intriguing new entry in the quest to understand human culture. Nonetheless, it has received relatively little philosophical attention. One notable exception is Kim Sterelny’s (2006) critique which raises three primary objections against the GCC account. Most importantly, he argues that GCC theory, as it stands, is unable to resolve “the paradox of cultural accumulation” (151); that while social learning should generally be prohibitively expensive for the pupils, it nonetheless occurs as the principle means (...) of disseminating novel information through a culture. Sterelny holds that this is best explained by supplementing the GCC models with strong cultural group selection pressures. I argue that this is not needed. To show this I elaborate upon Joseph Henrich and Francisco Gil-White’s (2001) information goods theory, developing it in terms of the market pressures that one would expect to find in an information economy. I indicate how such pressures contribute to an individual-level explanation of cultural accumulation that answers Sterelny’s concerns. (shrink)

Creating Future People offers readers a fast-paced primer on how new genetic technologies will enable parents to influence the traits of their children, including their intelligence, moral capacities, physical appearances, and immune systems. It deftly explains the science of gene editing and embryo selection, and raises the central moral questions with colorful language and a brisk style. Jonathan Anomaly takes seriously the diversity of preferences parents have, and the limits policymakers face in regulating what could soon be a global (...) market for reproductive technology. He argues that once embryo selection for complex traits happens it will change the moral landscape by altering the incentives available to parents. All of us will take an interest in the traits everyone else selects, and this will present coordination problems that previous writers on genetic enhancement have failed to consider. Anomaly navigates difficult ethical issues with vivid language and scientifically-informed speculation about how genetic engineering will transform humanity. Key Features: Offers clear explanations of scientific concepts Explores important moral questions without academic jargon Brings discoveries from different fields together to give us a sense of where humanity is headed. (shrink)

This article presents and evaluates arguments supporting that an approval procedure for genome-edited organisms for food or feed should include a broad assessment of societal, ethical and environmental concerns; so-called non-safety assessment. The core of analysis is the requirement of the Norwegian Gene Technology Act that the sustainability, ethical and societal impacts of a genetically modified organism should be assessed prior to regulatory approval of the novel products. The article gives an overview how this requirement has been implemented in (...) the regulatory practice, demonstrating that such assessment is feasible and justified. Even in situations where genome-edited organisms are considered comparable to non-modified organisms in terms of risk, the technology may have—in addition to social benefits—negative impacts that warrant assessments of the kind required in the Act. The main reason is the disruptive character of the genome editing technologies due to their potential for novel, ground-breaking solutions in agriculture and aquaculture combined with the economic framework shaped by the patent system. Food is fundamental for a good life, biologically and culturally, which warrants stricter assessment procedures than what is required for other industries, at least in countries like Norway with a strong tradition for national control over agricultural markets and breeding programs. (shrink)

A lively history of American libertarianism and its decay into dangerous fantasy. In 2010 in South Fulton, Tennessee, each household paid the local fire department a yearly fee of $75.00. That year, Gene Cranick's house accidentally caught fire. But the fire department refused to come because Cranick had forgotten to pay his yearly fee, leaving his home in ashes. Observers across the political spectrum agreed-some with horror and some with enthusiasm-that this revealed the true face of libertarianism. But libertarianism (...) did not always require callous indifference to the misfortunes of others. Modern libertarianism began with Friedrich Hayek's admirable corrective to the Depression-era vogue for central economic planning. It resisted oppressive state power. It showed how capitalism could improve life for everyone. Yet today, it's a toxic blend of anarchism, disdain for the weak, and rationalization for environmental catastrophe. Libertarians today accept new, radical arguments-which crumble under scrutiny-that justify dishonest business practices and Covid deniers who refuse to wear masks in the name of "freedom." Andrew Koppelman's book traces libertarianism's evolution from Hayek's moderate pro-market ideas to the romantic fabulism of Murray Rothbard, Robert Nozick, and Ayn Rand, and Charles Koch's promotion of climate change denial. Burning Down the House is the definitive history of an ideological movement that has reshaped American politics. (shrink)

The potential to collect brain data more directly, with higher resolution, and in greater amounts has heightened worries about mental and brain privacy. In order to manage the risks to individuals posed by these privacy challenges, some have suggested codifying new privacy rights, including a right to “mental privacy.” In this paper, we consider these arguments and conclude that while neurotechnologies do raise significant privacy concerns, such concerns are—at least for now—no different from those raised by other well-understood data collection (...) technologies, such as gene sequencing tools and online surveillance. To better understand the privacy stakes of brain data, we suggest the use of a conceptual framework from information ethics, Helen Nissenbaum’s “contextual integrity” theory. To illustrate the importance of context, we examine neurotechnologies and the information flows they produce in three familiar contexts—healthcare and medical research, criminal justice, and consumer marketing. We argue that by emphasizing what is distinct about brain privacy issues, rather than what they share with other data privacy concerns, risks weakening broader efforts to enact more robust privacy law and policy. (shrink)

The prelims comprise: Introduction Commerce, Ethics, and Science: Gene Sequencing Commercial Marketing of Genetic Tests Conclusion.

In Norway, the production andconsumption of organic food is still small-scale. Research on attitudes towards organic farming in Norway has shown that most consumers find conventionally produced food to be “good enough.” The level of industrialization of agriculture and the existence of food scandals in a country will affect consumer demand for organically produced foods. Norway is an interesting case because of its small-scale agriculture, few problems with food-borne diseases, and low market share for organic food. Similarities between groups (...) of consumers and producers of food, organic and conventional, when it comes to attitudes concerning environment, use of gene technology, and animal welfare have implications for understanding market conditions for organically produced food. The results of our study indicate that organic farmers and organic consumers in Norway have common attitudes towards environmental questions and animal welfare in Norwegian agriculture. Conventional farmers have a higher degree of agreement with the way agriculture is carried out today. Unlike organic farmers and consumers, conventional farmers do not see major environmental problems and problems with animal welfare in today's farming system. But like the organic farmers and consumers, and to a stronger degree than conventional consumers, conventional farmers renounce gene technology as a solution to environmental problems in agriculture. These results are discussed in relation to their importance for the market situation for organically produced foods. (shrink)

Poreskoro, with three cat and four dog heads and a snake with a forked tongue as his tail, is responsible for epidemics of contagious diseases in Romany folklore. The Pishachas of Vedic mythology lurk in charnel houses and graveyards, waiting for humans to infect with madness. In Christian demonology, Pythius is known as the ruler of the eighth circle of the Inferno, bestowing heinous and unspeakable tortures on those who have committed fraud. Demons are the stuff of legends, and they (...) are everywhere in mythology and theology. These are just three of the more than thirty I counted that start with the letter P.How lucky we are for the advent of science. A rational tonic, it scatters our demons, demystifying the world for us—or so, at least, we think. As Canales brilliantly shows in this book, our assumption has been far off the mark. In physics, computer science, genetics, neuroscience, and economics, not to mention in the very foundations of rationality itself, an underworld of imaginary creatures has sustained and continues to inhabit modern science. Scientific demons appear in many guises: as atomic and subatomic particle manipulators, as feedback and parallel-processing experts, as messengers who can travel faster than the speed of light, as computer-code spies, gene and bit selectors in evolution and in informatics, as triggers of cascades from the nano level to the level of full-blown ecological and astrophysical theaters. By inventing them, we have learned that causality does not always hold at the level of atoms, that the speed of message transmission is limited, that living systems spend energy, that perpetual-motion machines are impossible, and that there are corners of the universe we have not imagined.We have all heard of Laplace's Demon, and Maxwell's, but who knew that, borrowing from physics, the historian Henry Adams considered the action of demons in geopolitics or that the economist Paul Samuelson analyzed their role in producing more efficient markets? Who knew that the generation that gave us the Internet and artificial intelligence were tasked by their teachers in graduate school to insert as many demons as possible into their programs? Who among us has heard of Darwin's Demon, or Maxwell-Szilárd-Brillouin's, or Monod's, or Loschmidt's? Who is aware of Norbert Weiner's use of demons in conceptualizing cybernetics, or of the great scholar of Kabbalah Gershom Scholem's comparison between Israel's superfast computers and the Golem?As Canales shows convincingly, it has been difficult for both historians and scientists to countenance demons in science, and so they have been written out, in many ways and many instances, of the histories of which they are part and parcel. Thomas Kuhn and even the more radical philosopher Paul Feyerabend both failed to acknowledge in their social critiques of science the extent to which an imaginary underworld of beings has been constitutive of the modern scientific imagination. Ironically, it was the man who provided a hard-and-fast criterion by which to distinguish scientific and nonscientific pursuits, Karl Popper, who ultimately saw the light. Revisiting his classic book The Logic of Scientific Discovery from 1934, he clarified in Postscript to the Logic of Scientific Discovery in 1982 the extent to which every historical era has been characterized by a particular demon. We moderns believe that science is about facts and numbers, but we are mistaken. As Canales beautifully summarizes the stakes of her project, “What first sets science on its path of discovery—then as now—is the continued use of the imagination.”Tracking the fate of demons in modern thought from Descartes to Lord Kelvin to H. G. Wells to David Bohm, and from Conrad Hal Waddington to Henry Compton to Stephen Hawking and Steven Pinker, Bedeviled assumes that the demons of the church or of paganism and the demons of science differ and resemble each other in ways that can be usefully elaborated. What is more crucial, however, is how such demons become real, how they morph from fears to hopes, and from thought experiments into real experiments, and ultimately to things in this world like computer programs, transistors, and nanorobots. From weather systems to messenger RNAs to black holes, demons emerge everywhere. The hard question is: How does the imagination actually drive discovery and understanding? How does it change our world?Perhaps it has been a sidetrack to consider whether we have or have never been modern. Clearly, what reason will not allow, it perennially recruits for a shadowland that helps us to better see our world. Rather than aiming to exorcise science, one day, of all of its methodological and epistemological ghosts, perhaps we might make peace with the notion that every culture struggles with distinguishing truth from falsehood in its own unique way. Such struggles are sensitive to their times and are accomplished through leaps of imagination. But fear not: the debunking of “Western rationality” casts no wet blanket on the project of Enlightenment. If anything, as Canales writes, “an account of science that considers how scientists themselves do science only risks adding new insights into our repertoire of knowledge.” Perhaps, therefore, there is solace to be gained from the dictum, Always choose the Devil you know. Ultimately, there may be no other way forward. (shrink)

The project Euroscreen 2 has examined genetic screening and testing with particular reference to implications for insurance, commercialization through marketing of genetic tests direct to the public, and issues surrounding raising public awareness of these and other developments in genetics, including the practical experiment of a Gene Shop. This paper provides a snapshot of the three year project. The study groups work included monitoring developments in different European countries and exploring possibilities for regulation in insurance and commercialization together with (...) public attitudes to regulation. The success or failure of different strategies is not independent of public awareness. Exploration of policy, however, also requires examination of fundamental concepts such as solidarity and geneticization. (shrink)

As new biotechnologies are developed, the parallels with GM crops are often drawn. In this paper, I consider GM animals and contrast them with GM crops. I use a systems of innovation perspective to consider innovation, product markets and regulatory systems and suggest that whilst there are some parallels between GM crops and animals there are also clear differences. There are differences in the techniques used, the availability of single genes useful for transfer and the acceptability of 'failures'. Existing animal (...) breeding techniques are competitive with GM technologies and dissemination of GM animals into a population is difficult and time consuming. The structure of the industry is different between crops and livestock with large multinational companies largely absent in the production of farm livestock for breeding. Additionally animal welfare and ethical aspects are widely recognised as important in the context of GM animals, but the likely impacts of welfare and ethicsbased regulation on any GM animal production is not clear. All these differences are potentially important for the future trajectory of the technology. I also suggest that at present, the development of GM animals is being pulled in different directions by the opening up of technological possibilities and the emphasis on animal welfare and notions of animal integrity. (shrink)

The diverse ways that extreme climate events are expressed at the local level have represented a challenge for the development of transgenic “climate-ready” seeds. Based on the Argentinean “HB4” technology, this paper analyzes how ignorance and a sunflower gene are mobilized to overcome this difficulty in soy and wheat. HB4 seeds can be understood as myopic: the technology does not obstruct the capacity of soy and wheat plants to sense droughts, but it prevents their natural reaction, which would be (...) to put a halt on crop production and redirect their energy toward survival. Plants thus become “short-sighted” to droughts. Informed by ignorance studies and by the immunological concept of tolerance, this paper analyzes HB4 myopia as a type of nonhuman ignorance: an asset that allows plant breeders to achieve varied plant responses to droughts and to encode their capitalist values into plants’ DNA. Moreover, ignorance becomes a molecular commodity that can be selected, transferred between organisms, and traded in markets. HB4’s prioritization of production resonates with other technologies of climate adaptation and mitigation that do not promote structural changes to the capitalist system. (shrink)

The essays in this book discuss human behavior and the institutions of capitalism. The essays are non-technical and are written so as to be accessible to students of all disciplines and to all other persons interested in capitalism and in economic behavior. They often present unconventional views of the topics they discuss. Those containing unconventional views discuss self-interested behavior, selfish gene theory, the meaning and social function of private ownership, the externality problem, the nature of the firm and the (...) rise of capitalism. The essays are not meant to be a textbook, but they offer a useful supplementary reading source for courses in business, economics and law that deal with human behavior in the marketplace and with capitalism, ownership, markets and firms. (shrink)

Capitalism’s Expansion into the Realm of the Biosphere. The extension of the rule of industrial property over living organisms and their components – genes and cells, both human and non-human – since the end of the 1970s, has gone along with the emergence of new markets in science, biotechnology and in health. The article argues that the filing of patents to protect private claims on living matter is a development which promotes the establishment of a monopoly control over inventions in (...) the fields of medicine and agronomy, while at the same time fostering a restriction in exchanges within the scientific community. The article therefore argues the case for a declaration that genomes, human and non-human, be considered as a common good, in terms both of the research carried out for the improvement of plants and health and of the accessibility of the medical innovations resulting from such research. (shrink)